DF-003 demonstrates efficacy in mouse model of ROSAH syndromeALBANY, N.Y. & SHANGHAI--(BUSINESS WIRE)--Drug Farm, a clinical stage, biopharmaceutical company advancing two novel small molecule drugs ...

Oral presentation highlights potential utility of vantictumab for treatment of autosomal dominant osteopetrosis type 2 (ADO2) –– Poster documents benefit of MMP9 inhibition in a mouse model of ...

With limited treatment options for stroke patients available, two UConn researchers are developing an experimental drug that is capable of protecting the brain and improving recovery after a cerebral ...

The scale of Washington's F-35 is unprecedented, even in the history of America’s mega-projects. The enormous task was to ...

Sana Biotechnology, Inc. ( NASDAQ: SANA) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 11:30 AM EDT Well, hello, everyone. I'm Maxwell Skor, biotech analyst with Morgan ...